Search

Your search keyword '"Florencia G. Que"' showing total 128 results

Search Constraints

Start Over You searched for: Author "Florencia G. Que" Remove constraint Author: "Florencia G. Que" Topic business Remove constraint Topic: business
128 results on '"Florencia G. Que"'

Search Results

1. Implementation of prospective, surgeon-driven, risk-based pathway for pancreatoduodenectomy results in improved clinical outcomes and first year cost savings of $1 million

2. Complications and Outcomes Associated With Surgical Management of Renal Cell Carcinoma Involving the Liver: A Matched Cohort Study

Catalog

Books, media, physical & digital resources

3. Spontaneous Hepatic Hemorrhage: A Single Institution's 16-Year Experience

4. Metabolic Syndrome is Associated with Increased Postoperative Morbidity and Hospital Resource Utilization in Patients Undergoing Elective Pancreatectomy

5. Laparoscopic pancreatoduodenectomy does not completely mitigate increased perioperative risks in elderly patients

6. Management of a delayed post pancreatoduodenectomy haemorrhage using endovascular techniques

7. Model to predict survival after surgical resection of intrahepatic cholangiocarcinoma: the Mayo Clinic experience

8. Pancreaticoduodenectomy with Major Vascular Resection: a Comparison of Laparoscopic Versus Open Approaches

9. Surgical Resection of Synchronously Metastatic Adrenocortical Cancer

10. Portal Venous Thrombosis After Distal Pancreatectomy: Clinical Outcomes

11. Correlation of staging systems to survival in patients with resected hilar cholangiocarcinoma

12. Immediate post‐resection diabetes mellitus after pancreaticoduodenectomy: incidence and risk factors

13. Surgical Treatment of Malignant Pheochromocytoma and Paraganglioma: Retrospective Case Series

14. A multicenter randomized controlled trial comparing pancreatic leaks after TissueLink versus SEAMGUARD after distal pancreatectomy (PLATS) NCT01051856

15. Gastrointestinal stromal tumour of the duodenum: single institution experience

16. Role of operative therapy in treatment of metastatic gastrointestinal stromal tumors

17. Role of Operative Therapy in Non-cirrhotic Patients with Metastatic Hepatocellular Carcinoma

18. 15-Year Experience with Surgical Treatment of Duodenal Carcinoma: a Comparison of Periampullary and Extra-Ampullary Duodenal Carcinomas

19. Frequency of Subtypes of Biliary Intraductal Papillary Mucinous Neoplasm and Their MUC1, MUC2, and DPC4 Expression Patterns Differ from Pancreatic Intraductal Papillary Mucinous Neoplasm

20. Laparoscopic Assisted ERCP in Roux-en-Y Gastric Bypass (RYGB) Surgery Patients

21. Neoadjuvant Treatment of Duodenal Adenocarcinoma: A Rescue Strategy

22. Diagnosis and Treatment of Mirizzi Syndrome: 23-Year Mayo Clinic Experience

23. Hepatic Resection for the Carcinoid Syndrome in Patients with Severe Carcinoid Heart Disease: Does Valve Replacement Permit Safe Hepatic Resection?

24. NAFLD and Insulin Resistance Do Not Increase the Risk of Postoperative Complications Among Patients Undergoing Bariatric Surgery—A Prospective Analysis

25. Does Body Mass Index/Morbid Obesity Influence Outcome in Patients Who Undergo Pancreatoduodenectomy for Pancreatic Adenocarcinoma?

26. Hepatic Metastasectomy for Testicular Germ Cell Tumors: Is it worth it?

27. Incidence, Prevalence, and Management of Intraductal Papillary Mucinous Neoplasm in Olmsted County, Minnesota, 1984-2005

28. Decreasing Pancreatic Leak After Distal Pancreatectomy: Saline-coupled Radiofrequency Ablation in a Porcine Model

29. Hepatic Resection for Metastatic Neuroendocrine Cancer in Patients with Bone Metastases

31. Evidence of Surgical Management of Duodenal Cancer

32. MP70-12 IS CONCOMITANT HEPATIC RESECTION FOR LOCALLY ADVANCED OR METASTATIC RENAL CELL CARCINOMA AT THE TIME OF NEPHRECTOMY SAFE? A MATCHED COHORT STUDY

33. Clinical Risk Score to Predict Pancreatic Fistula after Pancreatoduodenectomy: Independent External Validation for Open and Laparoscopic Approaches

34. Preoperative anemia is associated with increased use of hospital resources in patients undergoing elective hepatectomy

35. What affects mortality after the operative management of hepatic abscess?

36. Quality-of-Life After Total Pancreatectomy: Is It Really That Bad on Long-term Follow-up?

37. Hepatic surgery for metastases from neuroendocrine tumors

38. Surgical Management of Abdominal Tuberculosis

39. Surgical outcomes of isolated caudate lobe resection: A single series of 19 patients

40. Pancreaticoduodenectomy for Islet Cell Tumors of the Head of the Pancreas: Long-term Survival Analysis

41. Total laparoscopic pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: oncologic advantages over open approaches?

42. Effect of reversible intermittent intra-abdominal vagal nerve blockade on morbid obesity: the ReCharge randomized clinical trial

43. Metastasectomy of neuroendocrine tumors in patients with multiple endocrine neoplasia type 1

44. Prospective Evaluation of Roux-en-Y Gastric Bypass as Primary Operation for Medically Complicated Obesity

45. Hemosuccus pancreaticus complicating chronic pancreatitis: an obscure cause of upper gastrointestinal bleeding

46. Management of peri-pancreatic vasculature during pancreatoduodenectomy: tips to avoid severe haemorrhage

47. Apoptosis: Cell death by proteolytic scalpel

48. Adenosquamous Carcinoma of the Pancreas: A Single-Institution Experience Comparing Resection and Palliative Care

49. Adenomas of the ampulla of Vater: a comparison of outcomes of operative and endoscopic resections

50. Adjunctive radiofrequency ablation of metastatic neuroendocrine cancer to the liver complements surgical resection